当前位置: X-MOL 学术Epilepsia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Post–COVID‐19 inflammatory syndrome manifesting as refractory status epilepticus
Epilepsia ( IF 5.6 ) Pub Date : 2020-09-18 , DOI: 10.1111/epi.16683
Elizabeth Carroll 1 , Henry Neumann 2 , Maria E Aguero-Rosenfeld 3 , Jennifer Lighter 4 , Barry M Czeisler 1, 5 , Kara Melmed 1, 5 , Ariane Lewis 1, 5
Affiliation  

There have been multiple descriptions of seizures during the acute infectious period in patients with COVID‐19. However, there have been no reports of status epilepticus after recovery from COVID‐19 infection. Herein, we discuss a patient with refractory status epilepticus 6 weeks after initial infection with COVID‐19. Extensive workup demonstrated elevated inflammatory markers, recurrence of a positive nasopharyngeal SARS‐CoV‐2 polymerase chain reaction, and hippocampal atrophy. Postinfectious inflammation may have triggered refractory status epilepticus in a manner similar to the multisystemic inflammatory syndrome observed in children after COVID‐19.

中文翻译:

COVID-19 后炎症综合征表现为难治性癫痫持续状态

对 COVID-19 患者在急性感染期的癫痫发作有多种描述。然而,没有关于从 COVID-19 感染中恢复后癫痫持续状态的报告。在此,我们讨论了一名在初次感染 COVID-19 后 6 周出现难治性癫痫持续状态的患者。广泛的检查显示炎症标志物升高、鼻咽 SARS-CoV-2 聚合酶链反应阳性复发和海马萎缩。感染后炎症可能以类似于 COVID-19 后在儿童中观察到的多系统炎症综合征的方式引发了难治性癫痫持续状态。
更新日期:2020-09-18
down
wechat
bug